tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Cash flow

Compare
0 Followers

SynAct Pharma AB Cash Flow

DE:8F8's free cash flow for Q2 2025 was kr-18.79K. For the 2025 fiscal year, DE:8F8's free cash flow was decreased by kr10.98M and operating cash flow was kr-18.79K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -89.20Mkr -100.18Mkr -117.56Mkr -65.00Mkr -33.24M
Investing Cash Flow
kr 0.00kr 370.00Kkr 27.00Kkr -6.00Kkr -93.00K
Financing Cash Flow
kr 87.41Mkr 53.98Mkr 200.71Mkr 74.32Mkr 44.72M
End Cash Position
kr 61.21Mkr 62.40Mkr 108.25Mkr 24.00Mkr 14.55M
Free Cash Flow
kr -89.20Mkr -100.18Mkr -117.56Mkr -65.00Mkr -33.24M
Currency in SEK

SynAct Pharma AB Cash Flow